S&P 500   5,044.20 (+0.44%)
DOW   38,010.74 (+0.68%)
QQQ   425.79 (-0.01%)
AAPL   167.88 (-0.07%)
MSFT   408.36 (-0.84%)
META   506.07 (+2.41%)
GOOGL   155.94 (+0.30%)
AMZN   181.21 (-0.04%)
TSLA   150.48 (-3.20%)
NVDA   845.83 (+0.65%)
AMD   154.69 (+0.44%)
NIO   3.99 (+2.05%)
BABA   69.24 (+0.61%)
T   16.16 (+0.25%)
F   12.09 (+0.42%)
MU   116.92 (+0.51%)
GE   157.72 (+1.32%)
CGC   7.06 (+8.78%)
DIS   113.39 (+0.40%)
AMC   2.79 (-6.38%)
PFE   25.35 (-0.28%)
PYPL   63.07 (-0.30%)
XOM   119.05 (+0.35%)
S&P 500   5,044.20 (+0.44%)
DOW   38,010.74 (+0.68%)
QQQ   425.79 (-0.01%)
AAPL   167.88 (-0.07%)
MSFT   408.36 (-0.84%)
META   506.07 (+2.41%)
GOOGL   155.94 (+0.30%)
AMZN   181.21 (-0.04%)
TSLA   150.48 (-3.20%)
NVDA   845.83 (+0.65%)
AMD   154.69 (+0.44%)
NIO   3.99 (+2.05%)
BABA   69.24 (+0.61%)
T   16.16 (+0.25%)
F   12.09 (+0.42%)
MU   116.92 (+0.51%)
GE   157.72 (+1.32%)
CGC   7.06 (+8.78%)
DIS   113.39 (+0.40%)
AMC   2.79 (-6.38%)
PFE   25.35 (-0.28%)
PYPL   63.07 (-0.30%)
XOM   119.05 (+0.35%)
S&P 500   5,044.20 (+0.44%)
DOW   38,010.74 (+0.68%)
QQQ   425.79 (-0.01%)
AAPL   167.88 (-0.07%)
MSFT   408.36 (-0.84%)
META   506.07 (+2.41%)
GOOGL   155.94 (+0.30%)
AMZN   181.21 (-0.04%)
TSLA   150.48 (-3.20%)
NVDA   845.83 (+0.65%)
AMD   154.69 (+0.44%)
NIO   3.99 (+2.05%)
BABA   69.24 (+0.61%)
T   16.16 (+0.25%)
F   12.09 (+0.42%)
MU   116.92 (+0.51%)
GE   157.72 (+1.32%)
CGC   7.06 (+8.78%)
DIS   113.39 (+0.40%)
AMC   2.79 (-6.38%)
PFE   25.35 (-0.28%)
PYPL   63.07 (-0.30%)
XOM   119.05 (+0.35%)
S&P 500   5,044.20 (+0.44%)
DOW   38,010.74 (+0.68%)
QQQ   425.79 (-0.01%)
AAPL   167.88 (-0.07%)
MSFT   408.36 (-0.84%)
META   506.07 (+2.41%)
GOOGL   155.94 (+0.30%)
AMZN   181.21 (-0.04%)
TSLA   150.48 (-3.20%)
NVDA   845.83 (+0.65%)
AMD   154.69 (+0.44%)
NIO   3.99 (+2.05%)
BABA   69.24 (+0.61%)
T   16.16 (+0.25%)
F   12.09 (+0.42%)
MU   116.92 (+0.51%)
GE   157.72 (+1.32%)
CGC   7.06 (+8.78%)
DIS   113.39 (+0.40%)
AMC   2.79 (-6.38%)
PFE   25.35 (-0.28%)
PYPL   63.07 (-0.30%)
XOM   119.05 (+0.35%)

PAVmed (PAVM) Earnings Date, Estimates & Call Transcripts

$1.96
-0.01 (-0.52%)
(As of 10:12 AM ET)
Skip Charts & View Estimated and Actual Earnings Data

PAVM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PAVM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

PAVmed Analyst EPS Estimates

Current Year EPS Consensus Estimate:($5.69) EPS

PAVM Earnings Date and Information

PAVmed has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 21st, 2024 based off prior year's report dates.

PAVmed Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/21/2024
Estimated)
------- 
11/14/2023Q3 2023-($1.65)($1.65)($0.06)-$0.79 million
8/15/2023Q2 2023-($1.35)($1.35)($0.04)-$0.17 million
5/16/2023Q1 2023-($1.50)($1.50)($0.01)-$0.45 million
3/14/2023Q4 2022-($2.25)($2.25)($0.07)-$0.11 million
11/15/2022Q3 2022-($3.15)($3.15)($0.13)-$0.08 million
8/16/2022Q2 2022-($2.55)($2.55)($0.05)--    
5/12/2022Q1 2022-($2.10)($2.10)($0.08)-$0.19 million
3/29/2022Q4 2021-($2.25)($2.25)($0.10)-$0.30 million    
11/22/2021Q3 2021-($2.25)($2.25)($0.15)-$0.20 million
8/12/2021Q2 2021($1.50)($2.10)($0.60)($0.02)--    
5/16/2021Q1 2021($1.80)($1.95)($0.15)($0.03)--  

PAVmed Earnings - Frequently Asked Questions

When is PAVmed's earnings date?

PAVmed has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 21st, 2024 based off last year's report dates. Learn more on PAVM's earnings history.

How much revenue does PAVmed generate each year?

PAVmed (NASDAQ:PAVM) has a recorded annual revenue of $2.45 million.

How much profit does PAVmed generate each year?

PAVmed (NASDAQ:PAVM) has a recorded net income of -$64.18 million. PAVM has generated -$9.33 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:PAVM) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners